Document is current
Any future updates will be listed below
-
Authors
Monteil, Vanessa https://orcid.org/0000-0002-2652-5695
Kwon, Hyesoo https://orcid.org/0000-0003-4637-4609
John, Lijo
Salata, Cristiano https://orcid.org/0000-0002-5136-7406
Jonsson, Gustav https://orcid.org/0000-0001-6692-8395
Vorrink, Sabine U.
Appelberg, Sofia https://orcid.org/0000-0002-7381-3606
Youhanna, Sonia
Dyczynski, Matheus
Leopoldi, Alexandra
Leeb, Nicole
Volz, Jennifer
Hagelkruys, Astrid https://orcid.org/0000-0003-3015-4038
Kellner, Max J.
Devignot, Stéphanie https://orcid.org/0000-0002-0618-5611
Michlits, Georg https://orcid.org/0000-0002-3337-8291
Foong-Sobis, Michelle
Weber, Friedemann https://orcid.org/0000-0001-9737-337X
Lauschke, Volker M. https://orcid.org/0000-0002-1140-6204
Horn, Moritz
Feldmann, Heinz https://orcid.org/0000-0001-9448-8227
Elling, Ulrich https://orcid.org/0000-0002-4514-2809
Penninger, Josef M. https://orcid.org/0000-0002-8194-3777
Mirazimi, Ali https://orcid.org/0000-0003-2371-6055
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2018-05766)
- License Information
-
More Information
Article History
Received: 2 March 2023
Accepted: 13 October 2023
First Online: 25 October 2023
Change Date: 4 February 2026
Change Type: Update
Change Details: In this article the affiliation 'Karolinska Institute and Karolinska University Hospital, Department of Laboratory Medicine, Unit of Clinical Microbiology, Stockholm, Sweden' for Hyesoo Kwon was missing. The original article has been updated.
Competing interests
: H.F. claims intellectual property of VSV-based filovirus vaccines. All other authors declare no conflicts of interest.
